DAKT vs MRK · P/E 35, rev $838.7M vs P/E 33, rev $16.61B
Daktronics Inc (DAKT) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Daktronics Inc (DAKT) is a electronic components company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Latest reported DAKT revenue for 2026-05-02 was $838.7M. Net income was $45.4M. Revenue was up 10.9% from 2025-04-26 to 2026-05-02. DAKT currently screens at market cap $932.1M and trailing P/E 34.8.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
DAKT currently screens at market cap $932.1M and trailing P/E 34.8. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the DAKT and MRK stock pages for the full models.
Not investment advice.